Evidence map›Paper›PMID 29970414›Full record

ArticleDiabetes care2018

Adiposity-Mortality Relationships in Type 2 Diabetes, Coronary Heart Disease, and Cancer Subgroups in the UK Biobank, and Their Modification by Smoking.

David A Jenkins, Jack Bowden, Heather A Robinson, Naveed Sattar, Ruth J F Loos, Martin K Rutter, Matthew Sperrin

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Association of combined healthy lifestyle factors with incident osteoporosis in patients with and without type 2 diabetes.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

David A JenkinsSchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, U.K. david.jenkins-5@manchester.ac.uk.ORCID 0000-0001-6687-3507
Jack BowdenMRC Integrative Epidemiology Unit, Population Health Sciences, University of Bristol, Bristol, U.K.
Heather A RobinsonSchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, U.K.
Naveed SattarInstitute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, U.K.ORCID 0000-0002-1604-2593
Ruth J F LoosThe Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Martin K RutterDivision of Endocrinology, Diabetes and Gastroenterology, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, U.K.
Matthew SperrinSchool of Health Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, U.K.
Manchester Academic Health Science Centre · GBChild Health and Development Institute · USUniversity of Bristol · GBUniversity of Glasgow · GB

Funding

Medical Research Council MC_PC_13042Medical Research Council MC_PC_17228Medical Research Council MC_QA137853Medical Research Council MC_UU_00011/2Medical Research Council MR/K006665/1
6 · The paper itself

Abstract

objectiveThe obesity paradox in which overweight/obesity is associated with mortality benefits is believed to be explained by confounding and reverse causality rather than by a genuine clinical benefit of excess body weight. We aimed to gain deeper insights into the paradox through analyzing mortality relationships with several adiposity measures; assessing subgroups with type 2 diabetes, with coronary heart disease (CHD), with cancer, and by smoking status; and adjusting for several confounders. RESEARCH DESIGN AND

methodsWe studied the general UK Biobank population (

resultsFor BMI, the obesity paradox was observed among people with type 2 diabetes (adjusted hazard ratio for obese vs. normal BMI 0.78 [95% CI 0.65, 0.95]) but not among those with CHD (1.00 [0.86, 1.17]). The obesity paradox was pronounced in current smokers, absent in never smokers, and more pronounced in men than in women. For other adiposity measures, there was less evidence for an obesity paradox, yet smoking status consistently modified the adiposity-mortality relationship.

conclusionsThe obesity paradox was observed in people with type 2 diabetes and is heavily modified by smoking status. The results of subgroup analyses and statistical adjustments are consistent with reverse causality and confounding.

Indexed as

Body Mass IndexAdiposityAdultAgedAged, 80 and overBiological Specimen BanksCoronary DiseaseDiabetes Mellitus, Type 2FemaleHumansMaleMiddle AgedNeoplasmsObesityOverweightRisk Factors

Identifiers

PMID29970414
OpenAlexW2807986286

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.